维普中文期刊产品整合服务
83篇 您的检索式:作者名="ROSINOL L"
    题名 作者 年代 出处 被引量
1Comparative genomic hybridization identifies two variants of smoldering multiple myeloma显示文摘Rosinol L Carrio A Blade J 2005Br J Haematol2005,130,5:1
2Bortezomib:A valuable new antineoplastic strategy in multiple myeloma显示文摘Blade J Cibeira MT Rosinol L 2005Acta Oncol2005,44,5:1
3Pathogenesis and treatment of renal failure in multiple myeloma显示文摘Dimopoulos MA Kastritis E Rosinol L 2008Leukemia2008,22,:1
4Comparative genomic hybridisation identifies two variants of smoldering multiple myeloma显示文摘Rosinol L Carrio A Blade J 2005Br J Haematol2005,130,5:1
5Renal, hematologic and infectious complications in multiple myeloma显示文摘Blade J Rosinol L 2005Best Prac Res Clin Haematol2005,18,4:1
6High-dose therapy intensification compared with continued standard chemotherapy in multiple nayeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA 显示文摘BLADE J ROSINOL L SUREDA A 2005Blood2005,106,12:1
7Pathogene-sis and treatment of renal failure in multlple myeloma显示文摘Dimopoulos MA Kastritis E Rosinol L 2008Leukemia2008,22,8:1
8Hema- topoietic stem cell transplantation for multiple myelo- ma beyond 2010显示文摘BLADE J ROSINOL L CIBEIRA M T 2010Blood2010,115,:1
9High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma显示文摘Paiva B Gutierrez NC Rosinol L 2012Blood2012,119,3:1
10Thalidomide in refractory and relapsing multiple myeloma显示文摘Blade J Esteve J Rosinol L 2001Semin Oncol2001,28,6:1
11A multicenter, randomized, doubleblind,placebo -controlled study of thalidomide plus dexamethasone versus dexamethasone as initial therapy for newly diagnosed multiple myeloma显示文摘Rajkumar SV Rosinol L Hussein M 2008Clin Oncol2008,26,:1
12Hematopoietic stem cell transplantation for multiple myeloma beyond 2010 显示文摘Blade J Rosinol L Cibeira MT 2010Blood2010,115,18:1
13Phase II Pethema trial of alternating bortezomib and dexamethasone as induction regimen before autologous stem-cell transplantation in younger patients with multiple myeloma: efficacy and clinical implications of tumor response kinetics显示文摘Rosinol L Oriol A Mateos MV 2007J Clin Oncol2007,25,:1
14High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustalned complete response after autologous stem cell transplantation in multiple myeloma 显示文摘Paiva B Gutierrez NC Rosinol L et at 2012Blood2012,119,3:1
15Borte- zomib/dexamethasone followed by autologous stem cell transplantation as front line treatment for light- chain deposition disease显示文摘TOVAR N CIBEIRA M T ROSINOL L 2012Eur J Haematol2012,89,:1
16Thalidomide in multiple myeloma: lack of response of soft-tissue plasmacytomas 显示文摘Blade J Perales M Rosinol L 2001Br J Haematol2001,13,:1
17Renal,hematologic and infectious complications in multiple myeloma显示文摘Blade J Rosinol L 2005Best Pract Res Clin Haematol2005,18,:1
18Pathogenesis and treatment of renal failure in multiple myeloma 显示文摘Dimopoulos M A Kastritis E Rosinol L 2008Leu- kemia2008,22,8:1
19Bortezomib:an efective agent in extramedullary disease in multiple myeloma 显示文摘Rosinol L Cibeira MT Uriburu C 2006Eur J Haematol2006,76,6:1
20Soft-tissue plasma- cytomas in multiple myeloma: incidence, mechanisms of extramed- ullary spread, and treatment approach显示文摘Blade J Femfndez de Larrea C Rosinol L 2011J Clin Oncol2011,29,28:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费